UCSF scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.

Researchers found that, when used alone, sequencing comes up short, missing some sick babies, while flagging many healthy ones for unnecessary follow-up testing. But sequencing can still be useful in cases that look suspicious but were not clearly identified by older screening technology.

UC San Francisco has spearheaded campaigns across the globe to stop the spread of deadly diseases such as malaria, measles and AIDS in developing countries. Now UCSF’s Institute for Global Health Sciences (IGHS) is building upon lessons learned to help low- and middle-income countries fight COVID-19, a disease that hits the poorest among us the hardest.

Lindsey A. Criswell has been selected as the next director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS) – the most common form of the illness, in which symptoms wax and wane.

New research by neuroscientists at the University of Pittsburgh and UC San Francisco revealed that a simple, earbud-like device developed at UCSF that imperceptibly stimulates a key nerve leading to the brain could significantly improve the wearer’s ability to learn the sounds of a new language.

As the official medical provider of the 2020 PGA Championship in San Francisco, UCSF Sports Medicine staff will be on-site to provide general first aid and immediate medical assistance.

The COVID-19 pandemic has led to a significant increase in video visits between patients and their doctors, but for many older adults, the shift has cut them off from care, rather than connecting them.